Pharmacokinetics and Pharmacodynamics Practice Questions

Q: Urinary alkalinizing agents are administered in case of poisoning due to which type of drugs?

Weak acids. **Explanation:** The principle behind urinary alkalinization is the **Ion Trapping Phenomenon**, which is governed by the Henderson-Hasselbalch equation. **1. Why Weak Acids are the Correct Answer:** Weakly acidic drugs (e.g., Salicylates, Phenobarbitone) exist in an equilibrium between ionized (charged) and unionized (uncharged) forms. In an alkaline medium (high pH), weak acids become **ionized**. Since ionized molecules are lipid-insoluble, they cannot diffuse back across the renal tubular epithelium into the bloodstream. This "traps" the drug in the tubular lumen, significantly increasing its renal clearance and excretion. **2. Why the Other Options are Incorrect:** * **Weak Bases:** In an alkaline urine, weak bases remain unionized (lipid-soluble), allowing them to be easily reabsorbed into the systemic circulation. To enhance the excretion of weak bases (e.g., Amphetamines), **urinary acidification** (using Ammonium Chloride) is required. * **Strong Acids/Bases:** These are already highly ionized at physiological pH levels. Their excretion is generally not significantly altered by minor shifts in urinary pH achieved through clinical alkalinization. **Clinical Pearls for NEET-PG:** * **Agent of Choice:** **Sodium Bicarbonate ($NaHCO_3$)** is the standard agent used to alkalinize urine (Target pH: 7.5–8.5). * **Classic Examples:** Forced alkaline diuresis is most commonly tested for **Salicylate (Aspirin)** and **Barbiturate** poisoning. * **Contraindication:** Do not alkalinize urine in patients with renal failure or congestive heart failure due to the risk of fluid and sodium overload. * **Mnemonic:** **"Like dissolves in Like"** (Unionized/Absorbed); **"Opposites Ionize"** (Ionized/Excreted). Acidic drug + Basic urine = Excretion.

Q: Which of the following characteristics is associated with a high volume of distribution for a drug?

Lipophilicity. The **Volume of Distribution ($V_d$)** is a theoretical volume that relates the amount of drug in the body to its plasma concentration ($V_d = \text{Total amount of drug} / \text{Plasma concentration}$). 1. Why Lipophilicity is Correct: Lipophilic (fat-soluble) drugs easily cross biological membranes and leave the vascular compartment to enter peripheral tissues and adipose stores [2]. Because the drug sequestered in tissues is not present in the plasma, the plasma concentration becomes very low. Mathematically, a low denominator (plasma concentration) results in a **high $V_d$** [1]. 2. Analysis of Incorrect Options: Hydrophilicity: Water-soluble drugs are polar and cannot easily cross lipid bilayers. They tend to remain confined to the plasma or extracellular fluid, resulting in a **low $V_d$**. High Protein Binding: Drugs that bind strongly to plasma proteins (like albumin) are "trapped" within the vascular compartment. This maintains a high plasma concentration, leading to a **low $V_d$**. (Conversely, high *tissue* binding increases $V_d$) [1]. Low Therapeutic Index: This refers to the safety profile of a drug (the ratio between toxic and effective doses) and has no direct physiological correlation with the volume of distribution. High-Yield Clinical Pearls for NEET-PG: Drug Example: **Chloroquine** has a massive $V_d$ (~15,000 L) because it binds extensively to tissues (retina/liver) [1]. Hemodialysis: Drugs with a high $V_d$ cannot be efficiently removed by hemodialysis because most of the drug is outside the bloodstream. Loading Dose: $V_d$ is the primary determinant used to calculate the Loading Dose ($LD = V_d \times \text{Target Plasma Concentration}$) [3]. Aging/Obesity: In elderly or obese patients, the $V_d$ for lipophilic drugs (e.g., Diazepam) increases due to a higher body fat percentage.

Q: Which is the most common cytochrome P450 enzyme associated with drug metabolism?

CYP3A4/5. **Explanation:** **1. Why CYP3A4/5 is the Correct Answer:** CYP3A4 is the most abundant and clinically significant cytochrome P450 isoform in humans. It accounts for approximately **30% of the total CYP content in the liver** and is responsible for the metabolism of nearly **50% of all clinically used drugs**. Its high expression in both the liver and the intestinal wall makes it a major determinant of first-pass metabolism and oral bioavailability. **2. Analysis of Incorrect Options:** * **CYP2D6 (Option B):** While it is the second most important enzyme and metabolizes about 25% of drugs (including beta-blockers, antidepressants, and opioids like codeine), it is highly **polymorphic**. It is not the most common by volume or total drug substrate count. * **CYP2C8/9 (Option C):** These metabolize roughly 15% of drugs. CYP2C9 is notable for metabolizing drugs with narrow therapeutic indices, such as **Warfarin** and **Phenytoin**. * **CYP2C19 (Option D):** This enzyme metabolizes about 5% of drugs, including **Clopidogrel** (a prodrug) and Proton Pump Inhibitors (PPIs). **3. High-Yield Clinical Pearls for NEET-PG:** * **Inducers of CYP3A4:** Rifampicin, Phenytoin, Carbamazepine, St. John’s Wort (Mnemonic: **GPRS Cell Phone** - Griseofulvin, Phenytoin, Rifampicin, Smoking, Carbamazepine, Phenobarbitone). * **Inhibitors of CYP3A4:** Ketoconazole, Erythromycin, **Grapefruit juice**, Ritonavir (Mnemonic: **VITAMIN K** - Valproate, Isoniazid, Troleandomycin, Amiodarone, Macrolides, Itraconazole, NNRTIs, Ketoconazole). * **Suicide Inhibitor:** Grapefruit juice irreversibly inhibits CYP3A4 in the intestinal wall. * **Genetic Polymorphism:** Most commonly associated with **CYP2D6** (Poor vs. Ultra-rapid metabolizers) and **CYP2C19**.

Q: The ratio of the median lethal dose to the median effective dose is the:

Therapeutic index. **Explanation:** The **Therapeutic Index (TI)** is a quantitative measurement of the relative safety of a drug. It is defined as the ratio of the dose that produces toxicity in 50% of the population (**Median Lethal Dose or $LD_{50}$**) to the dose that produces the desired clinical effect in 50% of the population (**Median Effective Dose or $ED_{50}$**). $$\text{Therapeutic Index} = \frac{LD_{50}}{ED_{50}}$$ A higher TI indicates a wider margin of safety, meaning a much larger dose is required to cause death than to achieve a cure. **Analysis of Incorrect Options:** * **Morbidity and Mortality Indices:** These are epidemiological terms used to measure the frequency of disease and death within a population, respectively; they are not used to describe drug dosage ratios. * **Anesthetic Ratio:** While related to the safety margin of anesthetic agents, it is not the standard pharmacological term for the $LD_{50}/ED_{50}$ ratio. **High-Yield Clinical Pearls for NEET-PG:** * **Narrow Therapeutic Index (NTI) Drugs:** These drugs require frequent **Therapeutic Drug Monitoring (TDM)** because small increments in dose can lead to severe toxicity. Mnemonic: **"WATT"** (**W**arfarin, **A**minoglycosides/Amphotericin B, **T**heophylline, **T**ricyclic Antidepressants) + **Lithium, Digoxin, and Phenytoin.** * **Certainty Safety Factor:** Since $LD_{50}$ and $ED_{50}$ only look at the 50% mark, the "Standard Safety Margin" ($LD_1/ED_{99}$) is often considered a more clinically relevant measure of safety. * **Penicillin** has a very high therapeutic index, while **Digoxin** has a very low (narrow) therapeutic index.

Q: True regarding the following is?

C is least potent.. ***C is least potent*** - **Potency** is determined by the **EC50 value** - the dose required to produce 50% of the maximum response; **curve C** is positioned furthest to the right, indicating the **highest EC50** and therefore the **least potency**. - In dose-response curves, **rightward shift** indicates decreased potency, meaning higher doses are needed to achieve the same effect. *A has the highest efficacy* - **Efficacy** refers to the **maximum response (Emax)** achievable, represented by the **height** of the dose-response curve, not the horizontal position. - All curves appear to reach similar maximum heights, so **curve A does not have superior efficacy** compared to others. *A has the least potency* - **Curve A** is positioned furthest to the **left**, indicating the **lowest EC50** and therefore the **highest potency**, not the least. - **Leftward position** on dose-response curves indicates **greater potency**, requiring lower doses to achieve effects. *D has the highest potency* - **Curve D** is not positioned furthest to the left; **curve A** appears to have the **leftmost position** indicating the highest potency. - **Potency ranking** from highest to lowest appears to be: **A > B > D > C** based on their horizontal positions.

Q: All of the following drugs act on ionic channels except?

Insulin. ### Explanation The correct answer is **Insulin (Option B)**. To answer this question, one must distinguish between the four major types of drug receptors: Ion channels, G-protein coupled receptors (GPCRs), Enzyme-linked receptors, and Intracellular receptors. **1. Why Insulin is the correct answer:** Insulin does not act on an ion channel. Instead, it binds to a **Tyrosine Kinase Receptor**, which is a type of **Enzyme-linked receptor**. Upon insulin binding, the intracellular domain of the receptor undergoes autophosphorylation, triggering a signaling cascade (via IRS-1/2 and PI3K pathways) that leads to the translocation of GLUT-4 transporters to the cell membrane. **2. Analysis of incorrect options:** * **Nicotine (Option A):** Acts on **Nicotinic Acetylcholine Receptors (nAChR)**, which are classic examples of **Ligand-gated ion channels** (ionotropic receptors). Binding allows the influx of sodium ($Na^+$) and potassium ($K^+$) ions. * **Glibenclamide (Option C):** This Sulfonylurea acts on the **ATP-sensitive Potassium ($K_{ATP}$) channels** in pancreatic beta cells. By closing these channels, it causes depolarization, leading to insulin release. * **Diazepam (Option D):** A Benzodiazepine that acts as a positive allosteric modulator of the **$GABA_A$ receptor**, which is a **Ligand-gated Chloride ($Cl^-$) channel**. **High-Yield Clinical Pearls for NEET-PG:** * **Fastest acting receptors:** Ligand-gated ion channels (milliseconds). * **Slowest acting receptors:** Nuclear/Intracellular receptors (hours to days). * **Enzyme-linked receptors:** Besides Insulin, Growth Factors (EGF, PDGF) and ANP also utilize this class. * **$K_{ATP}$ Channel:** Targeted by both Sulfonylureas (blockers) and Minoxidil/Diazoxide (openers).

Question 1

Urinary alkalinizing agents are administered in case of poisoning due to which type of drugs?

Accepted Answer

Weak acids

Answer

Weak bases

Answer

Strong bases

Answer

Strong acids

Question 2

Which of the following drug combinations represents psychological antagonism?

Accepted Answer

Prostacycline-thromboxane

Answer

Heparin-protamine

Answer

Adrenaline-phenoxybenzamine

Answer

Physostigmine-acetylcholine

Question 3

Which of the following characteristics is associated with a high volume of distribution for a drug?

Accepted Answer

Lipophilicity

Answer

Hydrophilicity

Answer

High protein binding

Answer

Low therapeutic index

Question 4

An elderly patient presents with myocardial infarction and a severe ventricular arrhythmia. The chosen antiarrhythmic drug has a narrow therapeutic window, with a minimum toxic plasma concentration 1.5 times the minimum therapeutic plasma concentration. The drug's half-life is 6 hours. It is crucial to maintain the plasma concentration above the minimum therapeutic level to prevent lethal arrhythmia. Which of the following dosing regimens is most appropriate?

Accepted Answer

Constant intravenous infusion

Answer

Once daily

Answer

Twice daily

Answer

Four times daily

Question 5

Which of the following is an ionic channel?

Accepted Answer

Nicotinic cholinergic receptors

Answer

$\alpha$1 receptors

Answer

$\beta$1 receptors

Answer

Muscarinic cholinergic receptors

Question 6

Which is the most common cytochrome P450 enzyme associated with drug metabolism?

Accepted Answer

CYP3A4/5

Answer

CYP2D6

Answer

CYP2C8/9

Answer

CYP2C19

Question 7

The ratio of the median lethal dose to the median effective dose is the:

Accepted Answer

Therapeutic index

Answer

Morbidity index

Answer

Mortality index

Answer

Anesthetic ratio

Question 8

True regarding the following is?

Accepted Answer

C is least potent.

Answer

A has the highest efficacy.

Answer

A has the least potency.

Answer

D has the highest potency.

Question 9

Regarding phenytoin, all are true except?

Accepted Answer

At lower concentration, it follows zero-order kinetics

Answer

Potent microsomal enzyme inducer

Answer

Highly protein bound

Answer

With increasing dose, the half-life increases

Question 10

All of the following drugs act on ionic channels except?

Accepted Answer

Insulin

Answer

Nicotine

Answer

Glibenclamide

Answer

Diazepam

Pharmacokinetics and Pharmacodynamics — MCQs

Pharmacokinetics and Pharmacodynamics — MCQs

On this page

Practice by Chapter

Want unlimited practice?